Supplementary Figure S1 from Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia

Authors:
  • HTHiroki Tanaka
    Hiroki Tanaka
  • HFHiroshi Fujiwara
    Hiroshi Fujiwara
  • FOFumihiro Ochi
    Fumihiro Ochi
  • KTKazushi Tanimoto
    Kazushi Tanimoto
  • NCNicholas Casey
    Nicholas Casey
  • SOSachiko Okamoto
    Sachiko Okamoto
  • JMJunichi Mineno
    Junichi Mineno
  • KKKiyotaka Kuzushima
    Kiyotaka Kuzushima
  • HSHiroshi Shiku
    Hiroshi Shiku
  • TSTakashi Sugiyama
    Takashi Sugiyama
  • ABA. John Barrett
    A. John Barrett
  • MYMasaki Yasukawa
    Masaki Yasukawa

Abstract
No abstract available